We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.42%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$23.5B
AUM Growth
+$825M
(+3.6%)
Cap. Flow
+$352M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
76
New
13
Increased
23
Reduced
16
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$785M |
| 2 |
T-Mobile US
TMUS
|
+$463M |
| 3 |
Mastercard
MA
|
+$428M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$352M |
| 5 |
Microsoft
MSFT
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$678M |
| 2 |
Elevance Health
ELV
|
+$674M |
| 3 |
AET
Aetna Inc
AET
|
+$333M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$279M |
| 5 |
TransDigm Group
TDG
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 22.63% |
| 2 | Healthcare | 21.02% |
| 3 | Consumer Discretionary | 15.15% |
| 4 | Energy | 12.34% |
| 5 | Technology | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Microsoft
MSFT
$3.71T
| $288M | 1.22% |
+5,633,782
| New | +$293M |
|
|
GPOR
27
DELISTED
Gulfport Energy Corp.
GPOR
| $280M | 1.19% |
8,956,338
-2,420,899
| -21% | -$73.3M |
|
|
RICE
28
DELISTED
Rice Energy Inc.
RICE
| $278M | 1.18% |
+12,613,321
| New | +$236M |
|
29
Trip.com Group
TCOM
$29.1B
| $265M | 1.13% |
6,431,269
| – | – |
|
|
SHPG
30
DELISTED
Shire pic
SHPG
| $214M | 0.91% |
1,162,787
+1,031,917
| +789% | +$186M |
|
|
PXD
31
DELISTED
Pioneer Natural Resource Co.
PXD
| $207M | 0.88% |
1,368,586
-1,186,582
| -46% | -$186M |
|
|
EVHC
32
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $198M | 0.84% |
2,610,964
+900,184
| +53% | +$64M |
|
33
American International
AIG
$41.3B
| $176M | 0.75% |
+3,334,968
| New | +$184M |
|
|
MRSH
34
Marsh
MRSH
$91.5B
| $175M | 0.74% |
2,552,071
+475,115
| +23% | +$30.5M |
|
|
WUBA
35
DELISTED
58.com Inc
WUBA
| $161M | 0.69% |
3,518,805
+620,906
| +21% | +$32M |
|
36
Hartford Financial Services
HIG
$39.3B
| $160M | 0.68% |
+3,600,912
| New | +$161M |
|
|
TYC
37
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $158M | 0.67% |
+3,541,981
| New | +$148M |
|
|
DYN
38
DELISTED
Dynegy, Inc.
DYN
| $157M | 0.67% |
9,132,705
+8,751,594
| +2,296% | +$152M |
|
|
SEE
39
DELISTED
Sealed Air
SEE
| $157M | 0.67% |
3,414,346
+2,942,812
| +624% | +$141M |
|
40
Humana
HUM
$46.2B
| $146M | 0.62% |
811,824
-416,549
| -34% | -$74M |
|
|
KITE
41
DELISTED
Kite Pharma, Inc.
KITE
| $126M | 0.54% |
2,525,497
+265,669
| +12% | +$13.1M |
|
42
Canadian Pacific Kansas City
CP
$80.5B
| $122M | 0.52% |
4,742,040
-6,755,210
| -59% | -$182M |
|
|
AET
43
DELISTED
Aetna Inc
AET
| $117M | 0.5% |
961,700
-2,896,103
| -75% | -$333M |
|
44
Jazz Pharmaceuticals
JAZZ
$16.7B
| $87.5M | 0.37% |
+618,862
| New | +$91.2M |
|
45
HCA Healthcare
HCA
$89.5B
| $83.9M | 0.36% |
+1,089,482
| New | +$86M |
|
46
Constellation Brands
STZ
$23.2B
| $76.9M | 0.33% |
465,183
-361,525
| -44% | -$56.6M |
|
47
Aon
AON
$76B
| $76.9M | 0.33% |
703,995
+132,439
| +23% | +$14M |
|
|
GWPH
48
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $76.1M | 0.32% |
+831,547
| New | +$70M |
|
49
Cigna
CI
$74.6B
| $64.2M | 0.27% |
501,208
+100,865
| +25% | +$13.3M |
|
50
NRG Energy
NRG
$24.8B
| $53.4M | 0.23% |
+3,562,472
| New | +$52.8M |
|
Similar funds
SAM
VIA
Viking Global Investors's Q2 2016 Portfolio in Review
As of Q2 2016, Viking Global Investors held 76 positions worth $23.5B, up 3.6% from $22.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Viking Global Investors's Q2 2016 filing shows 13 new, 23 increased, 16 reduced and 21 closed positions. Its largest new stake was Microsoft: 5,633,782 shares worth $288M. The largest sale was Allergan plc, an estimated $678M.
By sector, the portfolio is most concentrated in Communication Services at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Viking Global Investors's largest Q2 2016 buy was Microsoft: 5,633,782 shares worth $288M.
- Viking Global Investors added most to Biogen in Q2 2016, an estimated $785M increase.
- Viking Global Investors's biggest Q2 2016 reduction was Allergan plc, cutting an estimated $678M.
- Viking Global Investors fully exited Elevance Health in Q2 2016, selling an estimated $674M.
- Viking Global Investors's ten largest holdings make up 55% of its $23.5B portfolio in Q2 2016.
- Viking Global Investors opened 13 new positions and closed 21 in Q2 2016.
- Viking Global Investors's portfolio value rose 3.6% quarter-over-quarter to $23.5B.
Based on Viking Global Investors's 13F filing for Q2 2016, filed 15 Aug 2016.